Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:00 AM
Ignite Modification Date:
2025-12-25 @ 2:00 AM
NCT ID:
NCT02918760
Eligibility Criteria:
Inclusion Criteria:
* Moderate to severe chronic pelvic pain for at least 6 months.
* Pain was unrelated exclusively to menstruation.
* Pain incompletely relieved by Non-steroidal Ant-inflammatory drugs.
* Patients had regular menstrual cycles for 3 months.
* Patient receiving regular, effective contraceptive method.
Exclusion Criteria:
* Pregnancy or planning of pregnancy in next 6 months.
* Breast feeding.
* Acute pelvic infection.
* Known history of hypersensitivity to Gabapentin.
* Patients with severe renal or hepatic failure.
* Women with previous diagnosis of endometriosis confirmed by laparoscopy.
* Women with previous diagnosis of Malignancy.
* Plans for surgery in next 6 months.
* Women with chronic or recurrent gastrointestinal disease, including irritable bowel syndrome.
* Women with histories of alcohol use or other chronic tranquilizers. Patients refuse to sign an informed consent form.
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
45 Years
Study:
NCT02918760
Study Brief:
Protocol Section:
NCT02918760